Shilpa Medicare posted impressive Q2 FY25 results, sparking a 4% surge in its stock price and making it a stock to watch. The company reported significant gains in revenue, profitability, and margins, reflecting strong growth.
Key Financial Highlights
- Revenue: ₹348.8 crore, up 11% YoY and 16% QoQ.
- Gross Profit: ₹226.8 crore, a 20% YoY increase with a gross margin of 65%, up from 60% YoY.
- EBITDA: ₹91.0 crore, marking a 46% YoY rise and 10% QoQ growth; EBITDA margin rose to 26%.
- Net Profit (PAT): ₹18.0 crore, an impressive 1008% YoY growth and a 28% QoQ increase, with PAT margin expanding to 5%.
As of 9:34 am, Shilpa Medicare shares were trading 4.67% higher at Rs 863.40 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
TOPICS:
Shilpa Medicare